JP Morgan Chase’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3K Buy
+739
New +$22.8K ﹤0.01% 6691
2024
Q2
– Sell
-1,835
Closed -$44 – 7689
2024
Q1
$44 Buy
+1,835
New +$41.1K ﹤0.01% 7064

Other funds holding REVS

JP Morgan Chase's REVS Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q2 2026: 739 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #6691 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in REVS as recently as Q1 2024.

JP Morgan Chase first reported a position in REVS in Q1 2024 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • JP Morgan Chase held 739 shares of Columbia Research Enhanced Value ETF worth $23.3K as of Q2 2026.
  • Columbia Research Enhanced Value ETF was a new JP Morgan Chase position in Q2 2026.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6691 holding.
  • JP Morgan Chase first reported a position in Columbia Research Enhanced Value ETF in Q1 2024 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.